全球DNA定序市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

DNA定序市場預計將從2025年的193億美元成長到2034年的1,173.4億美元，預計從2026年到2034年將以22.21%的複合年成長率成長。

受基因組研究和生物技術進步的推動，全球DNA定序市場經歷了顯著成長。 DNADNA測序技術使科學家能夠精確定位遺傳物質中核苷酸的序列，從而加深對生物過程和疾病的理解。這些技術廣泛應用於醫學研究、藥物研發、農業和個人化醫療等領域。

DNA定序市場的主要促進因素包括基因組研究的增加和精準醫療需求的成長。醫療專業人員和研究人員正在利用定序技術來識別基因突變並開發標靶治療。此外，定序成本的降低和資料分析工具的改進也使得這些技術更容易被實驗室和研究機構所採用。

隨著基因組醫學的不斷發展，DNA定序市場依然前景看好。定序速度、準確性和成本的提升有望擴大其在臨床診斷和醫療領域的應用。生物技術和生命科學研究投入的增加預計將進一步加速創新和市場成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球DNA定序市場：依產品及服務分類

• 市場分析、洞察與預測
• 消耗品
• 裝置
• 服務

第5章 全球DNA定序市場：依技術分類

• 市場分析、洞察與預測
• 桑格法
• 次世代定序（全基因測序(WGS)、全EXOME定序(WES)、標靶定序與定序）
• 第三代DNA定序（單分子即時定序（SMRT）、奈米孔定序）

第6章 全球DNA定序市場：依工作流程分類

• 市場分析、洞察與預測
• 序列預處理
• 定序
• 數據分析

第7章 全球DNA定序市場：依應用領域分類

• 市場分析、洞察與預測
• 腫瘤學
• 生殖健康
• 臨床研究
• 農業基因組學與法醫學
• HLA型檢測/免疫系統監測
• 總體基因體學、流行病學和藥物發現
• 消費者基因體學
• 其他

第8章 全球DNA定序市場：依最終用途分類

• 市場分析、洞察與預測
• 學術研究
• 臨床研究
• 醫院和診所
• 製藥和生物技術公司
• 其他用戶

第9章 全球DNA定序市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific, Inc
  • Agilent Technology
  • IlluminaInc
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • MacrogenInc
  • PerkinElmer Genomics
  • PacBio
  • BGI
  • Bio-Rad LaboratoriesInc
  • Myriad Genetics
  • PierianDx
  • Partek Incorporated
  • Eurofins Scientific

The DNA Sequencing Market size is expected to reach USD 117.34 Billion in 2034 from USD 19.30 Billion (2025) growing at a CAGR of 22.21% during 2026-2034.

The global DNA sequencing market has experienced significant growth due to advancements in genomic research and biotechnology. DNA sequencing technologies allow scientists to determine the precise order of nucleotides in genetic material, enabling deeper understanding of biological processes and diseases. These technologies are widely used in medical research, drug discovery, agriculture, and personalized medicine.

Key drivers of the DNA sequencing market include increasing research in genomics and rising demand for precision medicine. Healthcare providers and researchers use sequencing technologies to identify genetic mutations and develop targeted treatments. Declining sequencing costs and improvements in data analysis tools have also made these technologies more accessible to laboratories and research institutions.

The future prospects of the DNA sequencing market remain highly promising as genomic medicine continues to evolve. Advances in sequencing speed, accuracy, and affordability may expand its use in clinical diagnostics and healthcare. Growing investments in biotechnology and life sciences research are expected to further accelerate innovation and market growth.

MARKET SEGMENTATION

By Product & Services

• Consumables
• Instruments
• Services

By Technology

• Sanger Sequencing
• Next-Generation SequencingA (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing)
• Third Generation DNA SequencingA (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing)

By Workflow

• Pre-sequencing
• Sequencing
• Data Analysis

By Application

• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Consumer Genomics
• Others

By End-use

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other Users

COMPANIES PROFILED

• Thermo Fisher Scientific, Inc, Agilent Technology, Illumina, Inc, QIAGEN, F HoffmannLa Roche Ltd, Macrogen, Inc, PerkinElmer Genomics, PacBio, BGI, BioRad Laboratories, Inc, Myriad Genetics, PierianDx, Partek Incorporated, Eurofins Scientific
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DNA SEQUENCING MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DNA SEQUENCING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Sanger Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Next-Generation Sequencing (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Third Generation DNA Sequencing (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DNA SEQUENCING MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Pre-sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DNA SEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Reproductive Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Clinical Investigation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Agrigenomics & Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. HLA Typing/Immune System Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Metagenomics, Epidemiology & Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Consumer Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DNA SEQUENCING MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Academic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Other Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DNA SEQUENCING MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Services
  • 9.2.2 By Technology
  • 9.2.3 By Workflow
  • 9.2.4 By Application
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Services
  • 9.3.2 By Technology
  • 9.3.3 By Workflow
  • 9.3.4 By Application
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Services
  • 9.4.2 By Technology
  • 9.4.3 By Workflow
  • 9.4.4 By Application
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Services
  • 9.5.2 By Technology
  • 9.5.3 By Workflow
  • 9.5.4 By Application
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Services
  • 9.6.2 By Technology
  • 9.6.3 By Workflow
  • 9.6.4 By Application
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DNA SEQUENCING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Thermo Fisher Scientific, Inc
  • 11.2.2 Agilent Technology
  • 11.2.3 IlluminaInc
  • 11.2.4 QIAGEN
  • 11.2.5 F. Hoffmann-La Roche Ltd
  • 11.2.6 MacrogenInc
  • 11.2.7 PerkinElmer Genomics
  • 11.2.8 PacBio
  • 11.2.9 BGI
  • 11.2.10 Bio-Rad LaboratoriesInc
  • 11.2.11 Myriad Genetics
  • 11.2.12 PierianDx
  • 11.2.13 Partek Incorporated
  • 11.2.14 Eurofins Scientific